Endothelin-1 (ET-1) activates two types of Ca 2ϩ -permeable nonselective cation channels (designated NSCC-1 and NSCC-2) and a store-operated Ca 2ϩ channel (SOCC) in Chinese hamster ovary cells expressing endothelin A receptors (CHO-ET A R). These channels can be distinguished by their sensitivity to Ca 2ϩ channel blockers 1- [385][386][387][388] ) ET A R (CHO-SerET A R), each of which is coupled with G q or G s /G 12 , respectively. In CHOSerET A R, a dominant-negative mutant of G 12 inhibited AA release. SK&F 96365 inhibited ET-1-induced AA release in CHO-ET A R⌬385, whereas LOE 908 inhibited it in CHO-SerET A R. These results indicate the following: 1) ET-1-induced AA release depends on Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCC in CHO-ET A R; 2) G q and G 12 mediate AA release through ET A R in CHO cells; and 3) PI3K is involved in ET-1-induced AA release, which depends on NSCC-2 and SOCC.
duced AA release. Wortmannin and LY294002, inhibitors of phosphoinositide 3-kinase (PI3K), partially inhibited ET-1-induced AA release. LOE 908, but not SK&F 96365, inhibited ET-1-induced AA release in wortmannin-treated CHO-ET A R. ET-1 also induced AA release in CHO [385] [386] [387] [388] ) ET A R (CHO-SerET A R), each of which is coupled with G q or G s /G 12 , respectively. In CHOSerET A R, a dominant-negative mutant of G 12 inhibited AA release. SK&F 96365 inhibited ET-1-induced AA release in CHO-ET A R⌬385, whereas LOE 908 inhibited it in CHO-SerET A R. These results indicate the following: 1) ET-1-induced AA release depends on Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCC in CHO-ET A R; 2) G q and G 12 mediate AA release through ET A R in CHO cells; and 3) PI3K is involved in ET-1-induced AA release, which depends on NSCC-2 and SOCC.
The release of arachidonic acid (AA) from the membrane lipids is catalyzed by phospholipase A 2 (PLA 2 ) in mammalian cells (Dennis, 1997) . Hormones and growth factors including endothelin-1 (ET-1) stringently regulate PLA 2 activity (Dennis, 1997; Leslie, 1997; Trevisi et al., 2002) . AA is converted into other biologically active metabolites such as leukotrienes, lipoxins, prostaglandins, and thromboxanes by different enzymes. These metabolites seem to play significant roles in several important processes, including vascular contraction and cell growth (Gong et al., 1995; Anderson et al., 1997) . Previous reports indicate that the key enzyme responsible for agonist-induced AA release is cytosolic PLA 2 (cPLA 2 ) (Lin et al., 1992; Roshak et al., 1994) . ET-1 also induces AA release through cPLA 2 activation (Trevisi et al., 2002) . cPLA 2 is a cytosolic 85-kDa Ca 2ϩ -dependent PLA 2 and is activated by both an increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and Ser-505 phosphorylation by mitogen-activated protein kinase or protein kinase C (Leslie, 1997) . Extracellular Ca 2ϩ influx plays critical roles in the ET-1-induced AA release (Stanimirovic et al., 1994; Wu-Wong et al., 1996) 
involved in ET-1-induced AA release. These uncertainties are mainly caused by the lack of specific Ca 2ϩ -channel blockers. We have recently shown that a sustained increase in [Ca 2ϩ ] i caused by ET-1 results from Ca 2ϩ entry through three types of voltage-independent Ca 2ϩ channel (VICC) into CHO cells expressing ET A R (CHO-ET A R): two types of Ca 2ϩ -permeable nonselective cation channels (designated NSCC-1 and NSCC-2) and a store-operated Ca 2ϩ channel (SOCC) (Kawanabe et al., 2001) . In particular, these channels can be distinguished using Ca 2ϩ -channel blockers such as SK&F 96365 and LOE 908. NSCC-1 is sensitive to LOE 908 and resistant to SK&F 96365; NSCC-2 is sensitive to both LOE 908 and SK&F 96365, and the SOCC is resistant to LOE 908 and sensitive to SK&F 96365 (Kawanabe et al., 2001 ). Thus, SK&F 96365 and LOE 908 may be useful for identifying which Ca 2ϩ channels are involved in ET-1-induced AA release in CHO-ET A R. Moreover, phosphoinositide 3-kinase (PI3K) was reported to be involved in the angiotensin IIinduced cPLA 2 activation and AA release in vascular smooth muscle cells (Silfani and Freeman, 2002) . PI3K plays essential roles in the activation of NSCC-2 and SOCC by ET-1 in CHO-ET A R (Kawanabe et al., 2002a) . Therefore, we examined the effects of PI3K on ET-1-induced AA release in CHO-ET A R.
Biological actions of ET-1 are mediated by two distinct receptor subtypes, ET A R and ET B R, that belong to a family of G protein-coupled receptors (Arai et al., 1990; Sakurai et al., 1990) . ET A R are functionally coupled with G q , G s , and G 12 in CHO cells (Aramori and Nakanishi, 1992; Kawanabe et al., 2002c) . Therefore, in the present study, we investigated which G protein subtypes were involved in ET-1-induced AA release. For this purpose, we used a dominant-negative mutant of G 12 (G 12 G228A) and two types of mutated ET A R designated ET A R⌬385 and SerET A R to clarify the involvement of G q , G s , and G 12 in ET-1-induced AA release. ET A R⌬385 lacks a C terminus downstream of Cys 385 and couples only with G q in CHO cells (Kawanabe et al., 2002c) . SerET A R is unpalmitoylated because of substitution of all of the cysteine-to-serine residues (Cys 383 Cys [385] [386] [387] [388] 3 Ser 383 Ser [385] [386] [387] [388] ) and couples with G s and G 12 in CHO cells (Kawanabe et al., 2002c) . Moreover, ET-1 activates SOCC in CHO-ET A R⌬385 and NSCC-1 in CHOSerET A R (Kawanabe et al., 2002b) .
Materials and Methods
Cell Culture. We used CHO-ET A R, CHO-ET A R⌬385, and CHOSerET A R, which were constructed as described previously (Kawanabe et al., 2002b,c) . CHO cells were maintained in Ham's F-12 medium supplemented with 10% fetal calf serum under a humidified 5% CO 2 /95% air atmosphere.
[ 3 H]Arachidonic Acid Release. The level of [ 3 H]arachidonic acid release was determined as described previously (Perez et al., 1993) . Briefly, cells in 100-mm dishes were incubated overnight with [ 3 H]arachidonic acid (final concentration, 1 Ci/ml). After washing, ET-1 was added for 5 min. The medium was then removed, acidified with 100 l of 1 N formic acid, and extracted with 3 ml of chloroform. The extracts were evaporated to dryness, resuspended in 50 l of chloroform, and applied to silica gel plates for thin-layer chromatography (Merck, Darmstadt, Germany). The plates were developed in heptane/diethyl ether/acetic acid/water (v/v, 75:25:4) . The distance of movement was visualized with iodine vapor. The location of arachidonic acid was verified with the use of a purified arachidonic acid (PerkinElmer Life Sciences, Boston, MA). The plate was scraped, and the radioactivity was counted with use of a liquid scintillation counter.
Transfection of G 12 G228A. We used G 12 G228A, which was constructed as described previously (Kawanabe et al., 2002b,c) . For transient expression, cells were transfected with plasmid (100 ng/l) encoding for G 12 G228A by the MBS Mammalian Transfection Kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. After 24 h of incubation, we used these cells for measurement of [
3 H]arachidonic acid release. Drugs. LOE 908 was kindly provided by Boehringer Ingelheim GmbH (Ingelheim, Germany). All other chemicals were of reagent grade and were obtained commercially.
Statistical Analysis. All results were expressed as mean Ϯ S.E.M. The data were subjected to a two-way analysis of variance. When a significant F value was encountered, the Newman-Keuls multiple range test was used to test for significant differences between treatment groups. A probability level of P Ͻ 0.05 was considered statistically significant.
Results
Effects of ET-1 on AA Release in CHO-ET A R. ET-1 induced AA release in a concentration-dependent manner with an EC 50 value of approximately 1 nM, and maximal effects were observed at concentrations Ն10 nM (Fig. 1A ). In the absence of extracellular Ca 2ϩ , the magnitudes of ET-1-induced AA release were near the basal level (Fig. 1B) . ET-1-induced AA release was abolished by BQ123, a specific antagonist of ET A R, but it was unaffected by BQ788, a specific antagonist of ET B R (Fig. 1B) . Moreover, ET-1-induced AA release was inhibited by arachydonyl trifluoromethyl ketone (AACOCF 3 ), a selective inhibitor of cPLA 2 .
Effects of SK&F 96365 and LOE 908 on ET-1-Induced AA Release in CHO-ET A R. SK&F 96365 inhibited ET-1-induced AA release in a concentration-dependent manner with IC 50 values of approximately 1 M (Fig. 2A) . Maximal inhibition was observed at concentrations Ն10 M. The extent of maximal inhibition was approximately 80% of ET-1-induced AA release (Fig. 2B) . Similarly, LOE 908 inhibited ET-1-induced AA release in a concentration-dependent manner with IC 50 values of approximately 1 M, and maximal inhibition was observed at concentrations Ն10 M (Fig. 2A) . The extent of maximal inhibition was approximately 60% of ET-1-induced AA release (Fig. 2B) . Moreover, the combined treatment with maximal effective concentration (10 M) of SK&F 96365 and LOE 908 completely inhibited ET-1-induced AA release (Fig. 2B) .
Effects of PI3K Inhibitors on ET-1-Induced AA Release in CHO-ET A R. Wortmannin inhibited ET-1-induced AA release in a concentration-dependent manner with IC 50 values of approximately 30 nM, and the maximal inhibition (ϳ80% of control) was seen at concentrations Ն1 M (Fig. 3) . ET-1-induced AA release in CHO-ET A R preincubated with 1 M wortmannin was inhibited by 10 M LOE 908 (Fig. 3B) . In contrast, 10 M SK&F 96365 failed to inhibit ET-1-induced AA release in CHO-ET A R preincubated with 1 M wortmannin (Fig. 3B) . We also used LY 294002, an inhibitor of PI3K, to evaluate the effects of PI3K on ET-1-induced AA release. LY 294002 at 50 M also inhibited ET-1-induced AA release (Fig. 3B) . ET-1-induced AA release was also sensitive to LOE 908 and resistant to SK&F 96365 in CHO-ET A R preincubated with 50 M LY 294002 (data not shown).
Effects of ET-1 on AA Release in CHO-ET A R⌬385 and CHO-SerET A R. ET-1 induced AA release in both CHO-ET A R⌬385 and CHO-SerET A R (Fig. 4) . However, the threshold concentrations of ET-1 for the induction of AA release were different. In CHO-ET A R⌬385, ET-1 induced AA release in a concentration-dependent manner with EC 50 values of between 1 and 10 nM, and maximal effects (approximately a 3.5-fold increase) were observed at concentrations Ն10 nM (Fig. 4) . Because CHO-ET A R⌬385 couples with G q but not with G S or G 12 (Kawanabe et al., 2002c) , G q plays essential roles on ET-1-induced AA release in these cells. In CHOSerET A R, ET-1 induced AA release in a concentration-dependent manner with EC 50 values of between 0.01 and 0.1 nM, and maximal effects (approximately a 2-fold increase) were observed at concentrations Ն0.1 nM (Fig. 4) .
Effects of G s and G 12 in ET-1-Induced AA Release in CHO-SerET A R. Because CHO-SerET A R couples with G S and G 12 (Kawanabe et al., 2002c) , we examined the effects of G S and G 12 on ET-1-induced AA release in these cells. Cholera toxin activates G S via a receptor-independent mechanism (Belevych et al., 2001) . Treatment with 1 g/ml cholera toxin failed to induce AA release (Fig. 5A) . Moreover, ET-1-induced AA release was not influenced by cholera toxin (Fig.  5A) .
G 12 G228A was transiently transfected to evaluate the role of G 12 . For this purpose, we used the MBS Mammalian Transfection Kit (Stratagene). When we transfected green fluorescent protein with this method, approximately 65% of the cells were green fluorescent protein-positive (data not shown). The magnitudes of ET-1-induced AA release in CHO-SerET A R transfected with G 12 G228A were approximately 70% of those in CHO-SerET A R (Fig. 5B) . The magnitudes of ET-1-induced AA release in CHO-SerET A R trans- Effects of SK&F 96365, LOE 908, and Wortmannin on ET-1-Induced AA Release in CHO-ET A R⌬385 and CHOSerET A R. In CHO-ET A R⌬385, ET-1-induced AA release was inhibited by SK&F 96365 in a concentration-dependent manner with IC 50 values of approximately 1 M, and complete inhibition was observed at concentrations Ն10 M (Fig.  6) . On the other hand, LOE 908 failed to inhibit ET-1-induced AA release in CHO-ET A R⌬385 (Fig. 6) . In addition, ET-1 failed to induce AA release in CHO-ET A R⌬385 pretreated with 1 M wortmannin (Fig. 6B) . In CHO-SerET A R, ET-1-induced AA release was inhibited by LOE 908 in a concentration-dependent manner with IC 50 values of approximately 1 M, and a complete inhibition was observed at concentrations Ն10 M (Fig. 7) . On the other hand, SK&F 96365 failed to inhibit ET-1-induced AA release in CHO-ET A R⌬385 (Fig. 7) . Moreover, the magnitudes of ET-1-induced AA release in CHO-SerET A R pretreated with 1 M wortmannin were similar to those observed in CHO-SerE-T A R (Fig. 7B) . LOE 908 also inhibited this wortmanninresistant part of ET-1-induced AA release (Fig. 7B) .
Discussion
ET-1 induces AA release in CHO-ET A R (Fig. 1A) . BQ123 inhibited ET-1-induced AA release, whereas BQ788 failed to inhibit it (Fig. 1B) . Therefore, ET-1-induced AA release is mediated by ET A R. Based on the sensitivity to AACOCF 3 (Fig. 1B) , ET-1 induces AA release through cPLA 2 activation. These results are in agreement with the observations in many cell types that agonist-induced AA release is mainly mediated by cPLA 2 (Ui et al., 1995; Wu-Wong et al., 1996; Kramer and Sharp, 1997; Trevisi et al., 2002) . In the absence of extracellular Ca 2ϩ , the magnitudes of ET-1-induced AA release were near the basal level (Fig. 1B) . Therefore, extracellular Ca 2ϩ influx plays a critical role in ET-1-induced AA release in CHO-ET A R as was also seen in vascular smooth muscle cells (Wu-Wong et al., 1996) . With the use of SK&F 96365 and LOE 908, we attempted to determine the effects of extracellular Ca 2ϩ influx through VICCs on ET-1-induced AA release. The inhibitory actions of SK&F 96365 and LOE 908 on ET-1-induced AA release are considered to be mediated by the blockade of Ca 2ϩ entry through VICCs for the following two reasons. First, in our recent work using patchclamp and [Ca 2ϩ ] i monitoring, ET-1 activates three types of VICCs in CHO-ET A R, namely NSCC-1, NSCC-2, and SOCC. In addition, LOE 908 was able to block both NSCC-1 and NSCC-2, whereas SK&F 96365 blocked NSCC-2 and SOCC (Kawanabe et al., 2001) . Second, the IC 50 values of these blockers for ET-1-induced AA release ( Fig. 2A) correlated well with those for ET-1-induced extracellular Ca 2ϩ influx (Kawanabe et al., 2001) . Three types of VICC seem to be involved in ET-1-induced AA release in terms of its sensitivity to SK&F 96365 and LOE 908 (Fig. 2B) : the first type of Ca 2ϩ channel is sensitive to LOE 908 and is resistant to SK&F 96365; the second type is sensitive to both LOE 908 and SK&F 96365; and the third type is resistant to LOE 908 Fig. 5 . A, effects of cholera toxin on AA release in resting CHO-SerET A R and CHO-SerET A R treated with ET-1. The cells were incubated for 60 min with 1 g/ml cholera toxin and then stimulated with or without 10 nM ET-1 for 5 min. B, effects of G 12 G228A on ET-1-induced AA release in CHO-SerET A R. CHO-SerET A R cells were transfected with G 12 G228A transiently as described under Materials and Methods. The cells were incubated with 10 nM ET-1 for 5 min. AA release was determined as described under Materials and Methods. Data presented are the mean Ϯ S.E.M. of three determinations, each done in triplicate. #, P Ͻ 0.05, significantly different from the control values stimulated by ET-1 in the absence of G 12 G228A in each experiment. and sensitive to SK&F 96365. Because of their pharmacological characteristics, these channels are considered to be NSCC-1, NSCC-2, and SOCC, respectively. The magnitudes of ET-1-induced AA release that were inhibited by the combined treatment with SK&F 96365 and LOE 908 were similar to those in the absence of extracellular Ca 2ϩ (Figs. 1B and 2B) . Therefore, extracellular Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCC plays an important role in ET-1-induced AA release in CHO-ET A R.
PI3K is involved in the activation of NSCC-2 and SOCC by ET-1 in CHO-ET A R (Kawanabe et al., 2002a) . Therefore, we investigated the effects of PI3K on ET-1-induced AA release in CHO-ET A R. The inhibitory effects of wortmannin on ET-1-induced AA release may be caused by its inhibitory effects on PI3K, as determined from the following data: 1) wortmannin is generally accepted as a PI3K inhibitor (Ui et al., 1995) . Moreover, at nanomolar concentrations, wortmannin acts specifically on PI3K (Yano et al., 1993) ; 2) Another PI3K inhibitor, LY294002, also inhibited the wortmannin-sensitive ET-1-induced AA release (Fig. 3B) ; and 3) the IC 50 values (ϳ30 nM) and maximal effective concentration (1 M) of wortmannin for ET-1-induced AA release (Fig. 3A) were similar to those for ET-1-induced phosphatidylinositol triphosphate formation, which was measured as an index of PI3K activity (Sugawara et al., 1996) . Moreover, the IC 50 values and maximal effective concentration of wortmannin for ET-1-induced AA release (Fig. 3A) were also similar to those for ET-1-induced Ca 2ϩ influx (Kawanabe et al., 2001 ). The wortmannin-resistant part of ET-1-induced AA release is dependent on extracellular Ca 2ϩ influx through NSCC-1, which is determined by the sensitivity to SK&F 96365 and LOE 908 (SK&F 96365-resistant and LOE 908-sensitive) (Fig. 3B) . Therefore, the wortmannin-sensitive part of ET-1-induced AA release is dependent on extracellular Ca 2ϩ influx through NSCC-2 and SOCC. These results indicate that PI3K is involved in the ET-1-induced AA release, which depends on NSCC-2 and SOCC.
To identify the G proteins involved in the AA release by ET-1, we used CHO-ET A R⌬385 and CHO-SerET A R. CHO-ET A R⌬385 and CHO-SerET A R couple with G q and with G s / G 12 , respectively (Kawanabe et al., 2002c) . ET-1 induced AA release in CHO-ET A R⌬385 (Fig. 4) . This result indicates that the G q pathway is involved in ET-1-induced AA release. In addition, ET-1 also induced AA release in CHO-SerET A R (Fig. 4) . Therefore, either G s and/or G 12 is required for ET-1-induced AA release. Cholera toxin had no effect on the resting AA release and in ET-1-induced AA release in CHOSerET A R (Fig. 5A) . These results indicate that ET-1-induced AA release is not mediated by the G s -dependent pathway. Disruption of signaling through endogenous G 12 by G 12 G228A inhibited ET-1-induced AA release in CHO-SerE-T A R (Fig. 5B) , indicating that the activation of AA release is mediated by G 12 . Therefore, G 12 and G q play important roles in ET-1-induced AA release. These results are consistent with the previous report, which demonstrated that the GTPase-deficient activated mutant of G 12 stimulates AA release in NIH 3T3 cells (Dermott et al., 1999) . ET-1-induced AA release was not inhibited completely by G 12 G228A in this study (Fig. 5B) . We believe that this is because G 12 G228A is not transfected to all cells. However, another possibility is that ET-1 induces AA release with another unknown pathway in CHO-SerET A R. Further research is necessary to confirm this. As determined from the sensitivity to SK&F 96365 and LOE 908 (SK&F 96365-sensitive and LOE 908-resistant), ET-1-induced AA release in CHO-ET A R⌬385 is dependent on extracellular Ca 2ϩ influx through SOCC (Fig. 6 ). On the other hand, ET-1-induced AA release is dependent on extracellular Ca 2ϩ influx through NSCC-1 in CHO-SerET A R (SK&F 96365-resistant and LOE 908-sensitive) (Fig. 7) . These results are in agreement with the previous observations that ET-1 activates SOCC in CHO-ET A R⌬385 or NSCC-1 in CHO-SerET A R (Kawanabe et al., 2002b) and that ET-1-induced SOCC or NSCC-1 activation is dependent on the G q -dependent pathway or the G 12 -dependent pathway, respectively (Kawanabe et al., 2002b) . The EC 50 values and maximal effects of ET-1 for AA release between CHO- ET A R⌬385 and CHO-SerET A R are different (Fig. 4A ). These differences seem to be the result of the sensitivity of NSCC-1 and SOCC to ET-1. NSCC-1 is activated by 0.1 nM ET-1, whereas SOCC is activated by 10 nM ET-1 in CHO-ET A R (Kawanabe et al., 2001) . These data also support the conclusion that extracellular Ca 2ϩ influx plays an essential role in ET-1-induced AA release. Because both the G q and G 12 pathways are necessary for NSCC-2 activation by ET-1 (Kawanabe et al., 2002b) , ET-1 failed to activate NSCC-2 in CHO-ET A R⌬385 and CHO-SerET A R. Therefore, the involvement of NSCC-2 in ET-1-induced AA release was not detected in these cells. However, taken from the data using CHO-ET A R, we concluded that NSCC-2 was also involved in ET-1-induced AA release.
In conclusion, extracellular Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCC plays an essential role in ET-1-induced AA release in CHO-ET A R. G q and G 12 are involved in ET-1-induced AA release through ET A R. In addition, PI3K acts as a regulator of ET-1-induced AA release, which depends on the extracellular Ca 2ϩ influx through SOCC and NSCC-2.
